Innovative Solutions for Neurodegenerative Diseases
At Stealth NewCo, we harness data-driven insights to discover small molecule therapeutics targeting neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS, guided by our eminent scientists and advanced biomarker strategies. Our scientific founders, on average, have 20+ years experience in drug development.
Pioneering Biotech Innovations
Transforming Drug Discovery
Our commitment to high throughput screening and biomarker measurement ensures we identify the most active and potent small molecules for effective treatment solutions in neurodegenerative disease management.
Innovative Solutions
We use the latest imaging and biochemistry techniques to screen small molecules for functional effects in cell-based neurodegenerative models. Promising molecules are subjected to multiple rounds of SAR by our biologist and medicinal chemists. Compounds with drug-like properties are advanced into small animal testing. .
We succeed through our rigorous reliance upon data, strict no-go criteria, absolute confidence in the science, and depth of our scientific team. We are not flashy, but our stealth allows us to be mighty.
Our Location
Located in the heart of biotech innovation in South San Francisco, we are dedicated to advancing therapeutics for neurodegenerative diseases.
Address
Oyster Point Blvd, South San Francisco